Improving patient safety through medicine risk communication: a theory-informed evaluation approach

AI and machine learning for predicting in vitro/preclinical drug toxicities and adverse events in clinical patients

Pharmacovigilance Signals and Determinants of Adverse Events Linked to Inhaled Asthma Medications: A Retrospective Analysis Using the FAERS Database

Pharmacovigilance in Antituberculosis Treatment: Ensuring Safety in Tuberculosis Management

How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women

Neoplasm Adverse Events Associated With Anti-Type 2 Biologics: An FAERS Database Pharmacovigilance Analysis Study

Interpol alerta del auge de antiparasitarios veterinarios promovidos como tratamientos contra el cáncer en humanos

Deviations from recommended use of liposomal bupivacaine: a real-world pharmacovigilance study using the FAERS database

Knowledge Graph for Cardiovascular Drug Safety and Pharmacovigilance: A Scoping Review

79th World Health Assembly adopts resolution to strengthen pharmacovigilance

Real-world pharmacovigilance analysis of drug-induced liver injury in 18-65 years: Based on the FDA adverse event reporting system (FAERS)

Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies

Sex-specific risk profiles of drug-associated joint stiffness and deformity: a FAERS-based pharmacovigilance study with Canadian Vigilance Adverse Reaction Database validation

Quality of adverse drug reaction reports submitted to the national pharmacovigilance center of Nepal: a pre-and post-training evaluation

WHO and African Medicines Agency launch landmark framework to strengthen access to quality-assured health products in Africa

Adverse Effects and Treatment Discontinuation of Blood Pressure–Lowering Drugs and Combinations. A Network Meta-Analysis

Minimizing Adverse Effects in Hypertension Treatment

The High Stakes of Pharmacovigilance: Why Specialized Partnership Outperforms the Large CRO Model

Immunomodulatory therapies and emerging drug associations with microscopic colitis: A global pharmacovigilance analysis

Counterfeit anti-rabies vaccine as a neglected issue: a manufacturers’ perspective

Association between ranitidine use and thyroid cancer based on FAERS and VigiAccess databases

Medication-related nephrotic syndrome: a real-world study from 2004 to 2024 based on the Food and Drug Administration Adverse Event Reporting System

Knowledge, attitude, and practice of undergraduate medical students toward pharmacovigilance and adverse drug reaction reporting: A questionnaire-based study

Post-marketing safety concerns with foscarbidopa/foslevodopa: A pharmacovigilance study with disproportionality analysis based on FAERS

Pharmacovigilance of semaglutide: A descriptive analysis of WHO-VigiAccess reports

Turning the tide on substandard and falsified medicines – the Medicine Quality, Innovation & Policy Conference, April 2026

How the VMD monitors the safety of animal medicines

Antibiotic Stewardship: Five Tips to Reduce Resistance

When Medicines Harm: A Systems Analysis of the 2022 Paediatric Acute Kidney Injury Epidemic in The Gambia

Disproportionality and Case-Based Evidence for a Possible Association Between Fluoroquinolones and Kounis Syndrome

Pharmacovigilance signal detection of central nervous system demyelinating diseases following human papillomavirus vaccination: data mining and signal analysis based on the VAERS database

Paroxysmal Nocturnal Hemoglobinuria and Vaccination: A Systematic Pharmacovigilance Analysis of 147 Cases

A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study

Integrating pharmacovigilance into quality and regulatory decision making: A systematic review

INTELIGENCIA ARTIFICIAL Y MEDICINA: DIEZ LECCIONES APRENDIDAS (Y OLVIDADAS): 1970-2026

Pharmacovigilance in Ayurveda: Ensuring Safe Use of Traditional Medicines

Prescription safety in elderly cardiology patients: a cross-sectional study

Optimizing cardiac patients safety: Assessing QT interval-prolonging drug alert in electronic prescription in hospitalized patients

Alerta de circulación irregular de fármacos para uso animal

Strengthening Global Drug and Vaccine Safety Through AI-Driven Pharmacovigilance: Myocarditis Signals, mRNA Vaccine AEFIs, and PV Infrastructure Assessment